 |
46 Diseases |  |
10 Trials |
|
10 Trials |  |
738 News |  |
| «12345678910 |
- ambrisentan / Generic mfg., aminophylline / Generic mfg.
New P1 trial: GQ02: A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude (clinicaltrials.gov) - Feb 14, 2013
P1, N=40, Recruiting, Sponsor: Thies Schroeder
- ambrisentan / Generic mfg.
Trial completion: Influence of Cytochrome CYP3A4-induction by St. John's Wort on the Steady State Pharmacokinetics of Ambrisentan (clinicaltrials.gov) - Jan 27, 2013
P1, N=20, Completed, Sponsor: Gerd Mikus
Recruiting --> Completed
- ||||||| ambrisentan / Generic mfg.
Trial completion: A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202) (clinicaltrials.gov) - Jan 13, 2013
P3, N=383, Completed, Sponsor: Gilead Sciences
Recruiting --> Completed Active, not recruiting --> Completed
- ambrisentan / Generic mfg.
New P1/2 trial: Ambrisentan for Treatment of Portopulmonary Hypertension (clinicaltrials.gov) - Nov 22, 2012
P1/2, N=10, Recruiting, Sponsor: Medical University of Graz
- ambrisentan / Generic mfg., aminophylline / Generic mfg.
Trial completion: GQ01: The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers (clinicaltrials.gov) - Nov 14, 2012
P1, N=18, Completed, Sponsor: Thies Schroeder
Active, not recruiting --> Completed Recruiting --> Completed
- Tracleer (bosentan) / J&J, Roche
New P2 trial: Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma (clinicaltrials.gov) - Jun 10, 2012
P2, N=18, Not yet recruiting, Sponsor: University of Glasgow
- Tracleer (bosentan) / J&J, Roche
Enrollment closed: SCOBA-PH: Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension (clinicaltrials.gov) - Apr 15, 2012
P4, N=110, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Recruiting --> Completed Recruiting --> Active, not recruiting
- | ambrisentan / Generic mfg.
Trial completion, Combination therapy: Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1) (clinicaltrials.gov) - Mar 19, 2012
P4, N=38, Completed, Sponsor: Gilead Sciences
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ambrisentan / Generic mfg., aminophylline / Generic mfg.
New P1 trial: GQ01: The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers (clinicaltrials.gov) - Feb 8, 2012
P1, N=18, Completed, Sponsor: Thies Schroeder